VR training shows promise for Kids' eye misalignment

NCT ID NCT06117813

Completed Disease control Sponsor: Nunaps Inc Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a virtual reality training program called Nu.T in 54 children aged 6 to 15 with intermittent exotropia, a condition where one eye occasionally turns outward. Half of the children used the Nu.T software to do visual exercises, while the other half received no treatment. The goal was to see if the training could improve stereopsis, or depth perception. The results could lead to a new, non-invasive option for managing this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nu.T (visual perceptual training software delivered via virtual reality)
What this could lead to: If it works, this could point toward a non-invasive, drug-free way to improve depth perception in children with intermittent exotropia.
What could go wrong: This is a small, early-stage trial with only 54 participants, and the control group received no treatment. The results may not apply to all patients, and the improvement may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERMITTENT EXOTROPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alternating exotropia intermittent squint

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERMITTENT EXOTROPIA

Contacts and locations

Locations

Asan Medical Center

Seoul, South Korea
Hangil Eye Hospital

Incheon, South Korea
Inje University Ilsan Paik Hospital

Goyang, South Korea
Konkuk University Hospital

Seoul, South Korea
Nowon Eulji Medical Center, Eulji University

Seoul, South Korea
Uijeongbu Eulji Medical Center, Eulji University

Uijeongbu-si, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.